Abstract
Background Reproductive tract infections (RTIs) including sexually transmitted infections (STIs), endogenous and iatrogenic infections are a major health concern globally, particularly among young women in developing nations. If untreated, they can lead to infertility, increased HIV susceptibility, and cervical cancer. This study examines RTI symptoms prevalence, risk factors, and hesitancy toward STI vaccination.
Methods A cross-sectional study was conducted among 1,920 urban women (predominantly aged 18-25) in Delhi/NCR using a structured questionnaire. Data on demographics, reproductive health, RTI symptoms, and vaccine awareness were analyzed using SPSS 20. Chi-square tests, Fisher’s exact tests, and Bonferroni corrections were applied, with multinomial logistic regression identifying RTI risk predictors.
Results Among respondents, 1,240 (64.6%) reported RTI symptoms, with 1,029 (83%) experiencing vaginal discharge and 974 (78.5%) vulval itching. Significant risk factors included early menarche, irregular menstrual cycles, poor menstrual hygiene, and prior RTI medication use. Additionally, 1,033 (53.8%) were hesitant about STI vaccination, citing safety concerns (36%, 372) and cost (18.6%, 192). However, 826 (43%) reported that healthcare provider recommendations positively influenced their decision to vaccinate.
Conclusion The high prevalence of RTI symptoms highlights the urgent need for improved awareness, accessible healthcare services, and stronger vaccination promotion efforts to enhance RTI prevention and management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Institute of Allergy and Infectious Diseases, National Institute of Health R01-AI117235
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by Institutional Human Ethics Committee, ACBR, University of Delhi
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
All data will be available on request from the corresponding authors.
